Exane BNP Paribas Downgrades Novartis to Neutral

Exane BNP Paribas analyst Richard Parkes downgrades Novartis (NYSE:NVS) from Outperform to Neutral.

Exane BNP Paribas analyst Richard Parkes downgrades Novartis (NYSE:NVS) from Outperform to Neutral.

Total
0
Shares
Related Posts